Renaissance Technologies’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.13M Buy
461,374
+122,900
+36% +$301K ﹤0.01% 2449
2025
Q1
$2.26M Buy
338,474
+119,955
+55% +$800K ﹤0.01% 1924
2024
Q4
$2.75M Buy
+218,519
New +$2.75M ﹤0.01% 1839
2024
Q3
Sell
-99,574
Closed -$2.14M 3815
2024
Q2
$2.14M Buy
+99,574
New +$2.14M ﹤0.01% 1844
2024
Q1
Sell
-62,674
Closed -$1.88M 4003
2023
Q4
$1.88M Sell
62,674
-130,800
-68% -$3.92M ﹤0.01% 1988
2023
Q3
$3.96M Buy
193,474
+164,600
+570% +$3.37M 0.01% 1433
2023
Q2
$574K Sell
28,874
-84,500
-75% -$1.68M ﹤0.01% 2800
2023
Q1
$1.94M Sell
113,374
-45,426
-29% -$778K ﹤0.01% 2049
2022
Q4
$3.11M Sell
158,800
-321,000
-67% -$6.28M ﹤0.01% 1793
2022
Q3
$7.66M Buy
479,800
+45,900
+11% +$733K 0.01% 1171
2022
Q2
$5.97M Buy
433,900
+277,400
+177% +$3.82M 0.01% 1432
2022
Q1
$2.48M Buy
156,500
+4,701
+3% +$74.6K ﹤0.01% 2068
2021
Q4
$3.31M Buy
151,799
+36,306
+31% +$793K ﹤0.01% 1793
2021
Q3
$3.45M Buy
115,493
+95,393
+475% +$2.85M ﹤0.01% 1690
2021
Q2
$890K Sell
20,100
-35,490
-64% -$1.57M ﹤0.01% 2724
2021
Q1
$2.47M Buy
+55,590
New +$2.47M ﹤0.01% 2086
2020
Q2
Sell
-93,600
Closed -$1.31M 3707
2020
Q1
$1.31M Buy
+93,600
New +$1.31M ﹤0.01% 2288
2019
Q4
Sell
-27,900
Closed -$325K 3702
2019
Q3
$325K Buy
+27,900
New +$325K ﹤0.01% 3013
2019
Q2
Sell
-17,301
Closed -$303K 3720
2019
Q1
$303K Sell
17,301
-18,517
-52% -$324K ﹤0.01% 3091
2018
Q4
$531K Sell
35,818
-31,007
-46% -$460K ﹤0.01% 2847
2018
Q3
$1.65M Sell
66,825
-196,820
-75% -$4.85M ﹤0.01% 2376
2018
Q2
$5.18M Buy
263,645
+95,970
+57% +$1.88M 0.01% 1771
2018
Q1
$3.14M Buy
+167,675
New +$3.14M ﹤0.01% 2081